These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28232577)

  • 1. Optical control of cell signaling by single-chain photoswitchable kinases.
    Zhou XX; Fan LZ; Li P; Shen K; Lin MZ
    Science; 2017 Feb; 355(6327):836-842. PubMed ID: 28232577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational Design and Synthesis of Diverse Pyrimidine Molecules Bearing Sulfonamide Moiety as Novel ERK Inhibitors.
    Halawa AH; Eskandrani AA; Elgammal WE; Hassan SM; Hassan AH; Ebrahim HY; Mehany ABM; El-Agrody AM; Okasha RM
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly.
    Tsai J; Qiu W; Kohen-Avramoglu R; Adeli K
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):211-8. PubMed ID: 17038630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a novel mitogen-activated protein kinase kinase 1/2 inhibitor with a unique mechanism of action for cancer therapy.
    Daouti S; Wang H; Li WH; Higgins B; Kolinsky K; Packman K; Specian A; Kong N; Huby N; Wen Y; Xiang Q; Podlaski FJ; He Y; Fotouhi N; Heimbrook D; Niu H
    Cancer Res; 2009 Mar; 69(5):1924-32. PubMed ID: 19244124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photoswitchable binders enable temporal dissection of endogenous protein function.
    Westberg M; Song D; Duong V; Fernandez D; Huang PS; Lin MZ
    bioRxiv; 2023 Sep; ():. PubMed ID: 37745504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational control.
    Aronov AM; Tang Q; Martinez-Botella G; Bemis GW; Cao J; Chen G; Ewing NP; Ford PJ; Germann UA; Green J; Hale MR; Jacobs M; Janetka JW; Maltais F; Markland W; Namchuk MN; Nanthakumar S; Poondru S; Straub J; ter Haar E; Xie X
    J Med Chem; 2009 Oct; 52(20):6362-8. PubMed ID: 19827834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma.
    Guenther MK; Graab U; Fulda S
    Cancer Lett; 2013 Sep; 337(2):200-9. PubMed ID: 23684925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SGK1 inhibits cellular apoptosis and promotes proliferation via the MEK/ERK/p53 pathway in colitis.
    Bai JA; Xu GF; Yan LJ; Zeng WW; Ji QQ; Wu JD; Tang QY
    World J Gastroenterol; 2015 May; 21(20):6180-93. PubMed ID: 26034353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissection of Kinase Isoforms through Orthogonal and Chemical Inducible Signaling Cascades.
    Zheng S; Fan X; Wang J; Zhao J; Chen PR
    Chembiochem; 2017 Aug; 18(16):1593-1598. PubMed ID: 28561913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric modulators of MEK1: drug design and discovery.
    Shang J; Lu S; Jiang Y; Zhang J
    Chem Biol Drug Des; 2016 Oct; 88(4):485-97. PubMed ID: 27115708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression-based screening for inhibitors of PDGFR signaling.
    Antipova AA; Stockwell BR; Golub TR
    Genome Biol; 2008; 9(3):R47. PubMed ID: 18312689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-16 inhibits pituitary adenoma cell proliferation via the suppression of ERK/MAPK signal pathway.
    Wang DW; Wang YQ; Shu HS
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1241-1248. PubMed ID: 29565480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEK1/2 Inhibitors: Molecular Activity and Resistance Mechanisms.
    Wu PK; Park JI
    Semin Oncol; 2015 Dec; 42(6):849-62. PubMed ID: 26615130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEK1/2 dual-specificity protein kinases: structure and regulation.
    Roskoski R
    Biochem Biophys Res Commun; 2012 Jan; 417(1):5-10. PubMed ID: 22177953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic inhibition of ovarian cancer cell growth by combining selective PI3K/mTOR and RAS/ERK pathway inhibitors.
    Sheppard KE; Cullinane C; Hannan KM; Wall M; Chan J; Barber F; Foo J; Cameron D; Neilsen A; Ng P; Ellul J; Kleinschmidt M; Kinross KM; Bowtell DD; Christensen JG; Hicks RJ; Johnstone RW; McArthur GA; Hannan RD; Phillips WA; Pearson RB
    Eur J Cancer; 2013 Dec; 49(18):3936-44. PubMed ID: 24011934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taurocholate Induces Connective Tissue Growth Factor Expression in Hepatocytes Through ERK-YAP Signaling.
    Yu B; Jin GN; Ma M; Liang HF; Zhang BX; Chen XP; Ding ZY
    Cell Physiol Biochem; 2018; 50(5):1711-1725. PubMed ID: 30384360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical in vivo evaluation of efficacy, pharmacokinetics, and pharmacodynamics of a novel MEK1/2 kinase inhibitor RO5068760 in multiple tumor models.
    Daouti S; Higgins B; Kolinsky K; Packman K; Wang H; Rizzo C; Moliterni J; Huby N; Fotouhi N; Liu M; Goelzer P; Sandhu HK; Li JK; Railkar A; Heimbrook D; Niu H
    Mol Cancer Ther; 2010 Jan; 9(1):134-44. PubMed ID: 20053779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-β inhibits osteogenesis by upregulating the expression of ubiquitin ligase SMURF1 via MAPK-ERK signaling.
    Sun X; Xie Z; Ma Y; Pan X; Wang J; Chen Z; Shi P
    J Cell Physiol; 2018 Jan; 233(1):596-606. PubMed ID: 28322449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway.
    Wu RS; Qiu EH; Zhu JJ; Wang JR; Lin HL
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):150-157. PubMed ID: 29364482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors.
    Morris EJ; Jha S; Restaino CR; Dayananth P; Zhu H; Cooper A; Carr D; Deng Y; Jin W; Black S; Long B; Liu J; Dinunzio E; Windsor W; Zhang R; Zhao S; Angagaw MH; Pinheiro EM; Desai J; Xiao L; Shipps G; Hruza A; Wang J; Kelly J; Paliwal S; Gao X; Babu BS; Zhu L; Daublain P; Zhang L; Lutterbach BA; Pelletier MR; Philippar U; Siliphaivanh P; Witter D; Kirschmeier P; Bishop WR; Hicklin D; Gilliland DG; Jayaraman L; Zawel L; Fawell S; Samatar AA
    Cancer Discov; 2013 Jul; 3(7):742-50. PubMed ID: 23614898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.